Lilly Sees India as Export Hub as Mounjaro Sales Surge
Eli Lilly has identified India as a strategic node in its global supply chain and intends to scale locally sourced manufacturing as part of a previously announced $1 billion contract manufacturing investment. Rapid uptake of Mounjaro in India has made it the company's top-selling medicine by value there, and Lilly plans further product launches and…